Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ESA label changes

ESA label changes

ESA label changes
FDA and Amgen agreed on changes to the labels on ESAs in March 2007 to reflect new safety data.

Read the full 252 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE